LIMITED JOINT MOBILITY AND LIPODYSTROPHY IN CHILDREN AND ADOLESCENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS

被引:14
作者
KAKOUROU, T
DACOUVOUTETAKIS, C
KAVADIAS, G
BAKOULA, C
ARONI, K
机构
[1] First Department of Pediatrics, Athens University, Athens
关键词
D O I
10.1111/j.1525-1470.1994.tb00094.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
One hundred forty-eight children, aged 11.9 +/- 3.7 years, who had insulin-dependent diabetes mellitus (IDDM) for 4.5 +/- 3.7 years and glycosylated Hb values (HbA1) of 10.5% +/- 4.5%, were examined for limited joint mobility (LJM) and lipodystrophy. In all diabetics, human biosynthetic insulin was used. Six hundred forty-eight pupils, aged 11.8 +/- 2.5 years, served as controls. LJM was found in 28.4% of the diabetics and in 7.5% of the controls (p < 0.001). The presence and severity of LJM was positively correlated with the duration of diabetes and negatively with height. There was no correlation between the presence of LJM and sex, chronological age, age of diabetes onset, HbA1 values, or retinopathy. Lipodystrophy at insulin injection sites was found in 37.1% of the diabetics. Hypertrophic lesions predominated. Our findings and those of the literature lead to the following conclusions: the prevalence of LJM in IDDM subjects of comparable age using Rosenbloom's criteria is almost uniform in all published studies (28%); the correlation, however, of prevalence and severity to different parameters presents discrepancies which cannot be interpreted at present. Human biosynthetic insulin does not protect from lipodystrophy and alterations of insulin injections still remain the only currently available preventive and therapeutic measure.
引用
收藏
页码:310 / 314
页数:5
相关论文
共 24 条
  • [1] Rosenbloom AL, Frias JL., Diabetes
  • [2] short stature and joint stiffness a new syndrome, Clin Res, 22, 92 A, (1974)
  • [3] Rosenbloom AL, Silverstein JH, Lezotte DC, Riley WJ, Maclaren NK., Limited joint mobility in diabetes mellitus of childhood: natural history and relationship to growth impairment, J Pediatr, 101, pp. 874-878, (1982)
  • [4] Rosenbloom AL, Silverstein JH, Lezotte DC, Richardson K, McCallum M., Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease, N Engl J Med, 305, pp. 191-194, (1981)
  • [5] Reimer-Veit M, Burger W, Kroll M, Oberdisse U, Hovener G, Enders I, Weber B., Prevalence and development of limited joint mobility in type I diabetic children and adolescents, Pediatr Adolesc Endocr, 17, pp. 111-121, (1988)
  • [6] Garg KS, Chase PH, Marshall G, Jackson WE, Holmes D, Hoops S, Harris S., Limited joint mobility in subjects with insulin‐dependent diabetes mellitus:relationship with eye and kidney complications, Arch Dis Child, 67, pp. 96-99, (1992)
  • [7] Clarke CF, Piesowicz AT, Spathis GS., Limited joint mobility in children and adolescents with insulin dependent diabetes mellitus, Ann Rheumatic Dis, 49, pp. 236-237, (1990)
  • [8] Ferland L, Ehrlich RM., Single‐peak insulin in the treatment of insulin‐induced fat atrophy, J Pediatr, 86, 5, pp. 741-743, (1975)
  • [9] Gouterman IH, Sibrack LA., Cutaneous manifestations of diabetes, Cutis, 25, pp. 45-54, (1980)
  • [10] Reeves WG, Allen BR, Tattersall RB., Insulin‐induced lipoatrophy: evidence for an immune pathogenesis, Br Med J, 230, pp. 1500-1503, (1980)